Literature DB >> 12457613

Regulation of early lymphocyte development by E2A family proteins.

Stephen Greenbaum1, Yuan Zhuang.   

Abstract

Lymphocytes develop from hematopoietic stem cells through a series of highly regulated differentiation events in the bone marrow and thymus. A number of transcription factors are known to collaborate in controlling the timing and specificity of gene expression required for these developmental processes to occur. The basic helix-loop-helix (bHLH) proteins encoded by the E2A gene have been shown to play particularly important roles in the initiation and progression of lymphocyte differentiation. Gene targeting experiments in mice have demonstrated a requirement for E2A proteins at the onset of B lymphocyte development. More recent studies have broadened our view on the function of E2A proteins at multiple stages of lymphopoiesis and in the regulation of lymphoid-specific gene expression. Here we review the mammalian E2A proteins and the accumulated evidence demonstrating central roles for E2A throughout early B and T lymphocyte development. We also speculate on the direction of future research on the mechanisms underlying the lineage and stage-specific functions of E2A in lymphopoiesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12457613     DOI: 10.1016/s1044532302000751

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  14 in total

1.  Differential functions for the transcription factor E2A in positive and negative gene regulation in pre-B lymphocytes.

Authors:  Stephen Greenbaum; Adam S Lazorchak; Yuan Zhuang
Journal:  J Biol Chem       Date:  2004-08-13       Impact factor: 5.157

2.  Identification of RANBP16 and RANBP17 as novel interaction partners for the bHLH transcription factor E12.

Authors:  Jun-Ho Lee; Shengli Zhou; Cynthia M Smas
Journal:  J Cell Biochem       Date:  2010-09-01       Impact factor: 4.429

Review 3.  Progression of regulatory gene expression states in fetal and adult pro-T-cell development.

Authors:  Elizabeth-Sharon David-Fung; Mary A Yui; Marissa Morales; Hua Wang; Tom Taghon; Rochelle A Diamond; Ellen V Rothenberg
Journal:  Immunol Rev       Date:  2006-02       Impact factor: 12.988

4.  Alcohol affects the late differentiation of progenitor B cells.

Authors:  Hao Wang; Huijuan Zhou; Simon Mahler; Robert Chervenak; Michael Wolcott
Journal:  Alcohol Alcohol       Date:  2010-11-22       Impact factor: 2.826

5.  A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice.

Authors:  K M Draheim; N Hermance; Y Yang; E Arous; J Calvo; M A Kelliher
Journal:  Oncogene       Date:  2010-11-08       Impact factor: 9.867

6.  E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia.

Authors:  Wen-Chieh Pi; Jun Wang; Miho Shimada; Jia-Wei Lin; Huimin Geng; Yu-Ling Lee; Rui Lu; Dongxu Li; Gang Greg Wang; Robert G Roeder; Wei-Yi Chen
Journal:  Blood       Date:  2020-07-02       Impact factor: 22.113

7.  A requirement for sustained ERK signaling during thymocyte positive selection in vivo.

Authors:  Lisa K McNeil; Timothy K Starr; Kristin A Hogquist
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-08       Impact factor: 11.205

8.  Pre-TCR-triggered ERK signalling-dependent downregulation of E2A activity in Notch3-induced T-cell lymphoma.

Authors:  Claudio Talora; Antonio F Campese; Diana Bellavia; Monica Pascucci; Saula Checquolo; Manuela Groppioni; Luigi Frati; Harald von Boehmer; Alberto Gulino; Isabella Screpanti
Journal:  EMBO Rep       Date:  2003-10-17       Impact factor: 8.807

Review 9.  Competition and collaboration: GATA-3, PU.1, and Notch signaling in early T-cell fate determination.

Authors:  Ellen V Rothenberg; Deirdre D Scripture-Adams
Journal:  Semin Immunol       Date:  2008-09-03       Impact factor: 11.130

10.  Distinct roles for E12 and E47 in B cell specification and the sequential rearrangement of immunoglobulin light chain loci.

Authors:  Kristina Beck; Mandy M Peak; Takayuki Ota; David Nemazee; Cornelis Murre
Journal:  J Exp Med       Date:  2009-09-14       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.